Search Constraints
« Previous |
51 - 60 of 606
|
Next »
Search Results
Select an image to start the slideshow
Investigating the crystallisation behaviour of pharmaceutical compounds confined within mesoporous materials
1 of 10
Scaleable oral dose formulations
2 of 10
Development of new approaches for understanding and optimizing antisolvent crystallization processes
3 of 10
Untargeted metabolomics and proteomics application of mass spectrometry: from biomarker identification within cells to their spatial localization on tissues
4 of 10
Application of high-resolution mass spectrometry with MSn fragmentation in the elucidation of double bond positions in fatty acids following formation of hydroperoxides and hydroxides, and application of derivatisation for improved sensitivity in fatty acid analysis
5 of 10
Integrated lab-scale continuous manufacturing of pharmaceutical products
6 of 10
Real world outcomes with systemic anti-cancer treatments for advanced melanoma : experience from the West of Scotland 2010-2018
7 of 10
Crystallisation thermodynamics and random forest classification for the prediction of crystallisation outcomes
8 of 10
Examination of cytotoxicity of Crotalus adamanteus and Crotalus scutulatus scutulatus venom on human skin melanoma and ovarian carcinoma cell lines
9 of 10
Behavioural, electrophysiological and pharmacological investigations on cell type-specific neural processing in different cortical and hippocampal brain regions
10 of 10